---
title: Cholestatic Liver Diseases
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Cholestatic Liver Diseases #ğŸš§ æ–½å·¥ä¸­

### Cholestatic Liver Diseases

##### Primary biliary cholangitis (PBC)

â€¢Â Â Â Etiology: Immune-mediated destruction of intrahepatic bile ducts, most common in females 40â€“50 yr

â€¢Â Â Â Clinical features: Fatigue, pruritus, jaundice

â€¢Â Â Â Diagnosis: At least two of following: AlkP >1.5Ã— ULN, \+anti-mitochondrial antibody, liver biopsy with destruction of interlobular bile ducts and destructive cholangitis

â€¢Â Â Â Treatment: First line: ursodiol slows progression. Second line: obeticholic acid in compensated cirrhosis. For advanced disease, liver transplantation.

##### Primary sclerosing cholangitis (PSC)

â€¢Â Â Â Etiology: Fibroinflammatory disorder of bile ducts, most common in men 20â€“30 yr. 80% patients have IBD (UC)

â€¢Â Â Â Clinical features: Patients are usually asymptomatic or may develop pruritus, abdominal pain, cholangitis

â€¢Â Â Â Diagnosis: MRCP or ERCP: â€œBeads on a stringâ€ of intrahepatic and extrahepatic ducts. Liver biopsy: Fibrous obliteration of the small bile ducts with an â€œonion skinâ€ appearance on pathology

â€¢Â Â Â Treatment: No effective treatment. Progressive disease that requires liver transplantation. High association with cholangiocarcinoma: Screen with q6â€“12mo LFTs, Ca19-9, MRCP

